India, Feb. 4 -- In a historic move, Uganda, in collaboration with the World Health Organization (WHO) and other global partners, has launched the first-ever clinical trial for a vaccine targeting the Sudan species of the Ebola virus.

The trial, initiated just four days after the confirmation of an outbreak on January 30, marks an unprecedented speed for a randomized vaccine trial in an emergency setting, WHO said in a press statement.

While licensed vaccines exist for the Ebola virus species formerly known as Zaire ebolavirus, no licensed vaccine is currently available for the Sudan species. If this candidate vaccine proves effective, it could play a pivotal role in controlling future outbreaks and pave the way for regulatory approval...